Protocol for the first global study capturing the patient-reported impact of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) in the real-world setting using a smartphone application
The first publication from our global ALSP study has been presented at the Global Genes RARE Patient Advocacy Summit, 2022.
See here for more of our publications in other indications.